Crystal structure of the mineralocorticoid receptor DNA binding domain in complex with DNA

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Hudson, William H ^a   Youn, Christine ^a   Ortlund, Eric A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; STEROID RECEPTOR; RECOMBINANT PROTEIN;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; CRYSTAL STRUCTURE; DNA BINDING; DNA RESPONSIVE ELEMENT; ENDOCRINE DISEASE; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; HUMAN; NEOPLASM; OVERLAPPING GENE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PSEUDOHYPOALDOSTERONISM; AMINO ACID SEQUENCE; CHEMISTRY; ESCHERICHIA COLI; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; PATHOLOGY; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; STRUCTURAL HOMOLOGY; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; CRYSTALLOGRAPHY, X-RAY; DNA; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PSEUDOHYPOALDOSTERONISM; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; STRUCTURAL HOMOLOGY, PROTEIN;

EID: 84906979408     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107000     Document Type: Article

References (60)

1. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M (2000) Multiple actions of steroid hormones-a focus on rapid, nongenomic effects. Pharmacol Rev 52: 513-556
2. Tsai M, O'Malley BW (1994) Molecular mechanisms of action of steroid/ thyroid receptor superfamily members. Annu Rev Biochem 63: 451-486
3. Rastinejad F, Huang P, Chandra V, Khorasanizadeh S (2013) Understanding nuclear receptor form and function using structural biology. J Mol Endocrinol 51: T1-T21
4. Bridgham JT, Carroll SM, Thornton JW (2006) Evolution of hormone-receptor complexity by molecular exploitation. Science 312: 97-101
5. Marver D, Stewart J, Funder JW, Feldman D, Edelman IS (1974) Renal aldosterone receptors: studies with (3H)aldosterone and the anti-mineralocorticoid (3H)spirolactone (SC-26304). Proc Natl Acad Sci U S A 71: 1431-1435
6. Van Eekelen JA, Jiang W, De Kloet ER, Bohn MC (1988) Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus. J Neurosci Res 21: 88-94
7. Herman JP, Patel PD, Akil H, Watson SJ (1989) Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. Mol Endocrinol 3: 1886-1894
8. Lombes M, Oblin ME, Gasc JM, Baulieu EE, Farman N, et al. (1992) Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ Res 71: 503-510
9. DeRijk RH, Wust S, Meijer OC, Zennaro MC, Federenko IS, et al. (2006) A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J Clin Endocrinol Metab 91: 5083-5089
10. Joels M, Karst H, DeRijk R, de Kloet ER (2008) The coming out of the brain mineralocorticoid receptor. Trends Neurosci 31: 1-7
11. Berger S, Bleich M, Schmid W, Cole TJ, Peters J, et al. (1998) Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism. Proc Natl Acad Sci U S A 95: 9424-9429
12. McGraw AP, McCurley A, Preston IR, Jaffe IZ (2013) Mineralocorticoid receptors in vascular disease: connecting molecular pathways to clinical implications. Curr Atheroscler Rep 15: 340
13. Ivanes F, Susen S, Mouquet F, Pigny P, Cuilleret F, et al. (2012) Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure. Eur Heart J 33: 191-202
14. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341: 709-717
15. Ueda K, Fujiki K, Shirahige K, Gomez-Sanchez CE, Fujita T, et al. (2014) Genome-wide analysis of murine renal distal convoluted tubular cells for the target genes of mineralocorticoid receptor. Biochem Biophys Res Commun 445: 132-137
16. Reddy TE, Pauli F, Sprouse RO, Neff NF, Newberry KM, et al. (2009) Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res 19: 2163-2171
17. Young MJ (2008) Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation. Curr Opin Nephrol Hy 17: 174-180
18. Rickard AJ, Morgan J, Bienvenu LA, Fletcher EK, Cranston GA, et al. (2012) Cardiomyocyte mineralocorticoid receptors are essential for deoxycorticosterone/ salt-mediated inflammation and cardiac fibrosis. Hypertension 60: 1443-1450
19. Chantong B, Kratschmar DV, Nashev LG, Balazs Z, Odermatt A (2012) Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells. J Neuroinflammation 9: 260
20. Barnes PJ (1998) Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 94: 557-572
21. Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, et al. (1995) Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9: 401-412
22. Caprio M, Newfell BG, la Sala A, Baur W, Fabbri A, et al. (2008) Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circ Res 102: 1359-1367
23. Hudson WH, Youn C, Ortlund EA (2013) The structural basis of direct glucocorticoid-mediated transrepression. Nat Struct Mol Biol 20: 53-58
24. Meijsing SH, Pufall MA, So AY, Bates DL, Chen L, et al. (2009) DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 324: 407-410
25. Otwinowski Z, Minor W (1997) Processing of X-ray Diffraction Data Collected in Oscillation Mode. Methods in Enzymology 276: 307-362
26. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, et al. (2010) PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213-221
27. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66: 486-501
28. Lu XJ, Olson WK (2003) 3DNA: A software package for the analysis, rebuilding and visualization of three-dimensional nucleic acid structures. Nucleic Acids Res 31: 5108-5121
29. Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372: 774-797
30. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, et al. (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6: pl1-pl1
31. Sartorato P, Cluzeaud F, Fagart J, Viengchareun S, Lombès M, et al. (2004) New naturally occurring missense mutations of the human mineralocorticoid receptor disclose important residues involved in dynamic interactions with deoxyribonucleic acid, intracellular trafficking, and ligand binding. Mol Endocrinol 18: 2151-2165
32. Boyer M, Poujol N, Margeat E, Royer CA (2000) Quantitative characterization of the interaction between purified human estrogen receptor alpha and DNA using fluorescence anisotropy. Nucleic Acids Res 28: 2494-2502
33. Kino T, Hurt DE, Ichijo T, Nader N, Chrousos GP (2010) Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal 3: ra8
34. Schena M, Freedman LP, Yamamoto KR (1989) Mutations in the glucocorticoid receptor zinc finger region that distinguish interdigitated DNA binding and transcriptional enhancement activities. Genes Dev 3: 1590-1601
35. Watson LC, Kuchenbecker KM, Schiller BJ, Gross JD, Pufall MA, et al. (2013) The glucocorticoid receptor dimer interface allosterically transmits sequencespecific DNA signals. Nat Struct Mol Biol 20: 876-883
36. Thomas-Chollier M, Watson LC, Cooper SB, Pufall MA, Liu JS, et al. (2013) A naturally occuring insertion of a single amino acid rewires transcriptional regulation by glucocorticoid receptor isoforms. Proc Natl Acad Sci U S A 110: 17826-17831
37. Kim S, Brostromer E, Xing D, Jin J, Chong S, et al. (2013) Probing allostery through DNA. Science 339: 816-819
38. Pujo L, Fagart J, Gary F, Papadimitriou DT, Claës A, et al. (2007) Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism. Hum Mutat 28: 33-40
39. Sartorato P, Lapeyraque A-L, Armanini D, Kuhnle U, Khaldi Y, et al. (2003) Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism. J Clin Endocrinol Metab 88: 2508-2517
40. Liang J, Shang Y (2013) Estrogen and Cancer. Annu Rev Physiol 75: 225-240
41. Tindall D, Lonergan P (2011) Androgen receptor signaling in prostate cancer development and progression. J Carcinog 10: 20
42. Daniel AR, Hagan CR, Lange CA (2011) Progesterone receptor action: defining a role in breast cancer. Expert Rev Endocrinol Metab 6: 359-369
43. Arora VK, Schenkein E, Murali R, Subudhi Sumit K, Wongvipat J, et al. (2013) Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade. Cell 155: 1309-1322
44. Vilasco M, Communal L, Mourra N, Courtin A, Forgez P, et al. (2011) Glucocorticoid receptor and breast cancer. Breast Cancer Res Treat 130: 1-10
45. Moschetta A, Tiberio L, Nascimbeni R, Villanacci V, Casella C, et al. (2013) The Decrease of Mineralcorticoid Receptor Drives Angiogenic Pathways in Colorectal Cancer. PLoS ONE 8: e59410
46. Leo JC, Guo C, Woon CT, Aw SE, Lin VC (2004) Glucocorticoid and mineralocorticoid cross-talk with progesterone receptor to induce focal adhesion and growth inhibition in breast cancer cells. Endocrinology 145: 1314-1321
47. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, et al. (2012) The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery 2: 401-404
48. Schwabe JWR, Chapman L, Finch JT, Rhodes D (1993) The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: How receptors discriminate between their response elements. Cell 75: 567-578
49. Zilliacus J, Carlstedt-Duke J, Gustafsson JA, Wright AP (1994) Evolution of distinct DNA-binding specificities within the nuclear receptor family of transcription factors. Proc Natl Acad Sci U S A 91: 4175-4179
50. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, et al. (2000) Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289: 119-123
51. Mune T, Rogerson FM, Nikkilä H, Agarwal AK, White PC (1995) Human hypertension caused by mutations in the kidney isozyme of 11b-hydroxysteroid dehydrogenase. Nat Genet 10: 394-399
52. Jeong Y, Xie Y, Xiao G, Behrens C, Girard L, et al. (2010) Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer. PLoS Med 7: e1000378
53. Di Fabio F, Alvarado C, Majdan A, Gologan A, Voda L, et al. (2007) Underexpression of mineralocorticoid receptor in colorectal carcinomas and association with VEGFR-2 overexpression. J Gastrointest Surg 11: 1521-1528
54. Walther RF, Atlas E, Carrigan A, Rouleau Y, Edgecombe A, et al. (2005) A serine/threonine-rich motif is one of three nuclear localization signals that determine unidirectional transport of the mineralocorticoid receptor to the nucleus. J Biol Chem 280: 17549-17561
55. Faresse N (2014) Post-translational modifications of the mineralocorticoid receptor: How to dress the receptor according to the circumstances? J Steroid Biochem Mol Biol 143: 334-342
56. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, et al. (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29: 308-311
57. Liu W, Wang J, Sauter NK, Pearce D (1995) Steroid receptor heterodimerization demonstrated in vitro and in vivo. Proc Natl Acad Sci U S A 92: 12480-12484
58. Fuse H, Kitagawa H, Kato S (2000) Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1). Mol Endocrinol 14: 889-899
59. Surjit M, Ganti KP, Mukherji A, Ye T, Hua G, et al. (2011) Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145: 224-241
60. John S, Sabo PJ, Thurman RE, Sung MH, Biddie SC, et al. (2011) Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat Genet 43: 264-268